Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS

Gynecologic and Obstetric Investigation

Volumn 55, Issue 2, 2003, Pages 88-95

  Krotkiewski, Marcin ^a,b   Landin, Kerstin ^a   Dahlgren, Eva ^a   Janson, Per Olof ^a   Holm, Göran ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE   (Sweden)

Author keywords

Androgens; Insulin; Leptin; Overweight; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANTIANDROGEN; DIANE; GOSERELIN; LEPTIN; TESTOSTERONE;

ADULT; ARTICLE; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MEGADOSE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; ANDROGEN ANTAGONISTS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; BLOOD GLUCOSE; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; BODY WEIGHT; C-PEPTIDE; CYPROTERONE ACETATE; DEHYDROEPIANDROSTERONE SULFATE; ETHINYL ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPOPROTEIN(A); OBESITY; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRIGLYCERIDES;

EID: 0038545228     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070180     Document Type: Article

References (34)

1. Barash JA, Cheung CC, Weigle DS, et al: Leptin is a metabolic signal to the reproductive systems. Endocrinology 1996;137:3144-3147.
2. Chelab FF, Lim ME, Lu R: Correction of the sterility defect in homozygous obese female by treatment with the human recombinant leptin. Nat Genet 1996;12:318-320.
3. Cioffi JA, Shafer AW, Inanicic TJ, et al: Novel B 219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. Nat Med 1996;2:585-589.
4. Ahima RS, Prabakron D, Mantzoros C, et al: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-254.
5. Saad MF, Damani S, Gingerich RL, et al: Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997;82:579-584.
6. Krotkiewski M, Holmgren E, Karlsson U, et al: Weight loss and cerebrospinal fluid leptin in obesity. Lancet 1998;351:415-416.
7. Pasquali R, Antenucci D, Casimiri F, et al: Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989;68:173-177.
8. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG: Central nervous system control of food intake. Nature 2000;404:661-671.
9. Nam SY, Kratzsch J, Kim KW, Kim KR, Lim SK, Marcus C: Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab 2001;86:4849-4853.
10. Krotkiewski M, Carlsson B: Lack of correlation between cerebrospinal fluid (CSF) leptin levels and appetite and satiety scores in obese women. Int J Obes 1998;22:S-3,027.
11. Westerterp-Plantenga MS, Saris WH, Hukshorn CJ, Campfield LA: Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr 2001;74:426-434.
12. Lejeune MP, Hukshorn CJ, Saris WH, Westerterp-Plantenga MS: Effect of dietary restraint durong and following pegylated recombinant leptin treatment (PEG-OB) of overweight men. Int J Obes 2002;26:S-1, S159, A603.
13. Chehab FF, Qiu J, Mounzih K, et al: Leptin and reproduction. Nutr Rev 2002;60:S39-S46.
14. Dahlgren E, Landin K, Krotkiewski M, et al: Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 1998;13:2706-2711.
15. Hammerstein J, Cupceancu B: Behandlung des Hirsutismus mit Cyproteroneazetate. Dtsch Med Wochenschr 1969;94:829-834.
16. Krotkiewski M, Björntorp P, Sjöström L, Smith U: Impact of obesity on metabolism in men and women. J Clin Invest 1983;72:1150-1162.
17. Forbes GB, Gallup J, Hurch JB: Estimation of total body fat from potassium-40 content. Science 1961;133:101-102.
18. Friedewald WT, Levy RI, Fredriksson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
19. Gidez LI, Miller GJ, Burstein M, et al: Separation and quantitation of subclasses of human plasma high-density lipoproteins by a simple precipitation procedure. Lipid Res 1982;23:1206-1223.
20. Chapman IM, Wittert GA, Norman RJ: Circulating leptin concentrations in polycystic ovary syndrome: Relation to anthropometric and metabolic parameters. Clin Endocrinol 1977;46:175-181.
21. Vicennati V, Gambineri A, Calzoni F, Casimirri F, et al: Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Metabolism 1998;47:988-992.
22. Laughlin GA, Morales AJ, Yen SSC: Serum leptin levels in women with polycystic ovary syndrome: The role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab 1997;82:1692-1696.
23. Mantzoros CS, Dunaif A, Flier JS: Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:1687-1691.
24. Rouru J, Anttila L, Koskinen P, et al: Serum leptin concentration in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:1697-1700.
25. Panidis DK, Rousso DH, Mataliotakis IM, et al: The influence of long-term administration of conjugated estrogens and antiandrogens to serum leptin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 2000;14:169-172.
26. Brzechffa PR, Jakimiuk AJ, Agarwal SK, et al: Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:4166-4169.
27. Krotkiewski M, Seidell JC, Björntorp P: Glucose tolerance and hyperinsulinemia in obese women: Role of adipose tissue distribution, muscle fibre characteristics and androgens. J Int Med 1990;228:385-392.
28. Landin K, Krotkiewski M, Smith U: Importance of obesity for the metabolic abnormalities associated with an abdominal fat distribution. Metabolism 1989;38:572-576.
29. Ehrmann DA, Cavaghan MK, Imperial J, et al: Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:524-530.
30. Morin-Papunen LC, Koivunen RM, Tomas C, et al: Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2566-2568.
31. Pasqualia R, Gambioneri A, Biscotti D, et al: Effect on long term treatment with metformin added to hypocaloric diet on body composition, fat distribution and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767-2774.
32. Kristensen K, Pedersen SB, Richelssen B: Interactions between sex steroid hormones and leptin in women: Studies in vivo and in vitro. Int J Obes 2000;24:1438-1444.
33. Considine RV, Sinha M, Heiman ML, et al: Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 1996;334:292-295.
34. De Pergola G, Giagulli VA, Garruti G, et al: Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index. Metabolism 1991;40:187-190.